Loading…
Back To Schedule
Wednesday, October 26 • 1:30pm - 2:15pm
A Look into the Future of Clinical Trials: DCT Today and Beyond

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
  • Discuss the pros/cons of hybrid versus completely virtual models
  • Navigate the effects of DCT on Clinical QA (e.g. Updating QMS to include additional SOPs, enhancing vendor management qualification and oversight process)
  • How to be Inspection Ready in a DCT-world
Moderators
avatar for Nikki Cammarata

Nikki Cammarata

Consultant, Halloran Consulting Group, Inc.
Nikki Cammarata has more than 7 years of experience in conducting early and late phase clinical trials.  Nikki’s role at Halloran is to use her experience within clinical operations and clinical systems to deliver accurate and efficient services to clients. She has experience as... Read More →

Speakers
avatar for Christiane Dinneen

Christiane Dinneen

Vice President Clinical Operation, Science37
Christiane Dinneen, Vice President, Clinical Operations joined Science 37 in January 2021. She oversees Project Management and the overall delivery of our studies.Christiane has been in the industry for almost 25 years, working in small and large CROs in both clinical and project... Read More →
avatar for Kimberly Hawkins

Kimberly Hawkins

Global Head of Clinical Project Operations & Dossier Delivery, Sanofi
Kim has 25 years of operational experience managing all phases of the drug development process. Kim started her career at Boston Medical Center as a Research Assistant working on pediatric AIDS and Oncology trials. After working in academia, she moved into industry and held various... Read More →
avatar for Shawna Ruffin

Shawna Ruffin

GCDO Trial Leader/Associate Director, The Janssen Pharmaceutical Companies of Johnson & Johnson

Wednesday October 26, 2022 1:30pm - 2:15pm EDT
  Decentralized Clinical Trials Summit, Panel Discussion